NASDAQ · Biotechnology

Marker Therapeutics, Inc. (MRKR) Stock

$0.97 +2.27% NASDAQ: MRKR Healthcare

Valuation

MetricValue
Price$0.97
Market Cap$16.20M
P/E Ratio-2.21
P/B Ratio1.68
P/S Ratio14.33
EPS (TTM)$-0.79
52-Week High$2.46
52-Week Low$0.84
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-56.96%
ROA-59.70%
ROCE-88.07%
Gross Margin-65.14%
Operating Margin-3.86%
Net Margin-706.23%
Debt/Equity0.00
Current Ratio8.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$4.0M$3.0M$7.0M$0
Operating Profit$-39.0M$-20.0M$-15.0M$-11.0M$-13.0M
Net Profit$-42.0M$-30.0M$-8.0M$-11.0M$-12.0M
EPS$-5.47$-3.58$-1.93$-1.19$-0.79
Op Margin-3179.3%-563.3%-440.4%-168.7%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$68.0M$34.0M$17.0M$22.0M$19.0M
Total Liabilities$24.0M$15.0M$3.0M$3.0M$2.0M
Cash$42.0M$12.0M$15.0M$19.0M$16.0M
Borrowings$12.0M$8.0M$0$0$0

Latest News

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker Zacks · Jun 26, 2026 5 Small Drug Stocks to Invest in Amid a Biotech Comeback Zacks · Jun 25, 2026 Exploring 3 High Growth Tech Stocks in US Market Simply Wall St. · Jun 15, 2026 Exploring High Growth Tech Stocks In The US Market Simply Wall St. · Jun 11, 2026 Exploring 3 High Growth Tech Stocks in the US Market Simply Wall St. · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-27.0M$-27.0M$-16.0M$-11.0M$-12.0M
Investing Cash Flow$-6.0M$-5.0M$19.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$22.0M$-32.0M$3.0M$4.0M$-2.0M
Free Cash Flow$-30.0M$-27.0M$-16.0M$-11.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.73
FCF Yield-55.20%
Quick Ratio6.03
Interest Coverage0.00
Return 1Y-10.19%
Return 3Y-73.19%
Return 5Y-93.68%

Ownership

Insiders Held5.49%
Institutions Held23.31%
Institutions Float Held24.66%
Institutional HolderSharesReport Date
NEA Management Company, LLC1,625,6782026-03-31
Blue Owl Capital Holdings LP554,2502026-03-31
Vanguard Capital Management LLC389,3192026-03-31
Aisling Capital Management LP325,3702026-03-31
Renaissance Technologies, LLC175,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AEONAEON Biopharma, Inc. $0.28 -10.97% -0.08 $12.19M 0.00%
BOLTBolt Biotherapeutics, Inc. $4.11 +12.60% -0.22 $7.90M 0.00%
CLRBCellectar Biosciences, Inc. $1.45 +3.57% -0.39 $11.59M 0.00%
COCPCocrystal Pharma, Inc. $1.07 +0.00% -1.49 $14.75M 0.00%
EVGNEvogene Ltd. $0.38 -4.09% -0.44 $3.29M 0.00%

About Marker Therapeutics, Inc.

Marker Therapeutics, Inc. is led by CEO Juan F. Vera, employs 5 people, headquartered in US, publicly traded since 2002.

Marker Therapeutics, Inc. (MRKR) stock trades at $0.97 with a market capitalization of $16.20M. The stock is valued at a price-to-earnings (P/E) ratio of -2.21, price-to-book of 1.68, price-to-sales of 14.33. Over the past 52 weeks the stock has ranged between $0.84 and $2.46, and currently trades 60.6% below its 52-week high.

On profitability, Marker Therapeutics, Inc. generates a return on equity (ROE) of -56.96%, return on capital employed of -88.07%, an operating margin of -3.86%, a net profit margin of -706.23%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides